12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Other News

Pfizer neurology news

Healthcare investment company HealthCare Royalty Partners announced select 2012 product investments, including an undisclosed royalty interest in Pfizer's neuropathic pain drug Lyrica pregabalin from an undisclosed inventor. HealthCare Royalty said it believes this is...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >